Cookies & Privacy

We use essential cookies to make our site work. With your permission, we’ll also use analytics and marketing cookies to improve your experience. You can change your choice anytime.

See our Privacy Policy for details.

Manage preferences
Back to Industry News
Medtech

Swereco Halts Sales of its Eva Support Following Serious Incidents

Summary generated with AI, editor-reviewed
Heartspace News Desk
Source: Medtech Magazine
TL;DR

Swereco AB suspended sales of the Eva standing support due to safety concerns, including fatalities, reported between 2021 and 2025. These incidents involved users becoming entrapped between the device and their beds, particularly when used with soft mattresses or improperly installed with gaps exceeding 4 centimeters.

Key takeaways

  • Swereco AB has temporarily suspended sales of its Eva standing support device following consultation with the Swedish Medical Products Agency (Läkemedelsverket)
  • This action is a result of reported safety concerns, including fatalities, associated with the device's use
  • Between 2021 and 2025, eight accidents involving the Eva support aid were reported
Swereco AB has temporarily suspended sales of its Eva standing support device following consultation with the Swedish Medical Products Agency (Läkemedelsverket). This action is a result of reported safety concerns, including fatalities, associated with the device's use. Between 2021 and 2025, eight accidents involving the Eva support aid were reported. Seven of these incidents involved users becoming entrapped between the device and their beds, leading to serious injuries or death. Swereco has determined that the risk of entrapment is elevated when the device is used with soft mattresses lacking firm edges or when improperly installed, creating a gap exceeding 4 centimeters between the device and the bed. Swereco advises that existing devices can be used safely if the mattress provides sufficient firmness and the device is properly mounted. The company is currently revising the user manual and developing a new accessory designed to mitigate the risk of entrapment. Sales are anticipated to resume in early 2026, pending completion of the accessory and its distribution to customers.

Related Topics

medtechSwerecoproduct recallsafetyhealthcaremedical devices

Verified mention available

Free to claim

Is this your company?

Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.

Set up alerts Takes under 1 minute • Verified manually

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original